URMC »Research » Research@URMC Blog » October 2013

October 2013

Testicular Cancer: A Good News/Bad News Story

First, the good news: The survival rate for testicular cancer is 95 percent at 10 years, due to the invention of cisplatin-based chemotherapy in the 1970s. Despite this success, however, survivors have an increasing risk of second malignancies -- and the risk remains elevated for 35 years.

10/9/2013 | 0 comments